tiprankstipranks
TipRanksTop Financial ExpertsInsidersPatrick Enright

Patrick Enright Insider Profile

11 Followers
Patrick Enright, Director at Zenas BioPharma, Inc., holds 2.62M shares in Zenas BioPharma, Inc. (Ticker: ZBIO), holds ― shares in BioAge Labs, Inc. (Ticker: BIOA), holds 2.05M shares in Veradermics, Incorporated (Ticker: MANE). Most recently, Patrick Enright Bought ― shares of Zenas BioPharma, Inc. on Oct 14, 2025 for an estimated value of $2.25M.
See the Hottest Stocks Based on Insider Trading >
tipranks
Patrick Enright

Patrick Enright
Zenas BioPharma, Inc. (ZBIO)
Director

Ranked #15,137 out of 108,328 Corporate Insiders

Profitable Transactions

50%
16 out of 32 Profitable Transactions

Average Return

+5.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$499M
43.21%
34.74%
16.50%
4.47%
1.08% Others
A breakdown of Patrick Enright's holdings
See the Top Stocks by Insiders

Insider Roles

Veradermics, Incorporated
(MANE)
Director, Ten Percent Owner
Vera Therapeutics
(VERA)
Director
Zenas BioPharma, Inc.
(ZBIO)
Director
Corcept Therapeutics
(CORT)
Director, Ten Percent Owner
+2 other positions
Roles that Patrick Enright holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Vera Therapeutics
(VERA)
Rating:Informative Buy
Date:Feb 08, 2023 - Feb 08, 2024
Return:+418.70%
The most profitable trade made by Patrick Enright
See the Latest Stocks Traded by Insiders

Patrick Enright's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ZBIO
Zenas BioPharma, Inc.
Oct 14, 2025
Director
Informative Buy
2.25M
$82.35M
BIOA
BioAge Labs, Inc.
―
Director
―
―
MANE
Veradermics, Incorporated
Feb 05, 2026
Director, Ten Percent Owner
Uninformative Buy
―
$215.61M
AIMT
Aimmune Therapeutics
Oct 14, 2020
―
Uninformative Sell
270.48K
$0.00
APTX
Aptinyx
Jan 14, 2020
―
Informative Buy
785.00K
$331.37K
VERA
Vera Therapeutics
Dec 15, 2025
Director
Informative Buy
249.99K
$173.34M
JAZZ
Jazz Pharmaceuticals
Jan 08, 2026
Director
Uninformative Sell
―
$5.41M
CORT
Corcept Therapeutics
Mar 20, 2017
Director, Ten Percent Owner
Informative Sell
2.68M
$22.32M
ESPR
Esperion
Mar 23, 2015
―
Informative Sell
55.83M
$58.39K
MTEMQ
Molecular Templates
―
―
―
$14.38
SQNM
Sequenom
―
―
―
$1.84K
List of latest transactions for each holding click on a transaction to see Patrick Enright's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Patrick Enright insider profile FAQ

What is the percentage of profitable transactions made by Patrick Enright?
The percentage of profitable transactions made by Patrick Enright is 50%.
    What is the average return per transaction made by Patrick Enright?
    The average return per transaction made by Patrick Enright is 5.80%.
      What stocks does Patrick Enright hold?
      Patrick Enright holds: ZBIO, BIOA, MANE, AIMT, APTX, VERA, JAZZ, CORT, ESPR, MTEMQ, SQNM stocks.
        What was Patrick Enright’s latest transaction?
        Patrick Enright latest transaction was an Informative Buy of $2.25M.
          What was Patrick Enright's most profitable transaction?
          Patrick Enright’s most profitable transaction was an Informative Buy of VERA stock on February 8, 2023. The return on the trade was 418.70%.
            What is Patrick Enright's role in Zenas BioPharma, Inc.?
            Patrick Enright's role in Zenas BioPharma, Inc. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.